Agenus (AGEN) Common Equity (2010 - 2026)
Agenus (AGEN) posted quarterly Common Equity of -$228.0 million for Q1 2026, up 29.29% year-over-year from -$176.3 million in Q1 2025, and up 17.95% quarter-over-quarter from -$277.9 million in Q4 2025.
Agenus (AGEN) Common Equity (2010 - 2026) Analysis & Trends
Agenus' Common Equity history runs 17 years deep, the most recent figure standing at -$228.0 million for Q1 2026.
- In Q1 2026, Common Equity rose 29.29% year-over-year to -$228.0 million; the TTM figure through Mar 2026 stood at -$228.0 million (up 29.29% YoY), while the FY2025 annual figure was -$277.9 million, up 9.32% from the prior year.
- Common Equity for Q1 2026 stood at -$228.0 million, up from -$277.9 million in the prior quarter.
- The five-year high for Common Equity was $27.6 million in Q1 2022, with the low at -$336.3 million in Q2 2025.
- The 5-year median for Common Equity is -$190.3 million (2024), against an average of -$167.9 million.
- The sharpest annual moves came in 2022 and 2023: Common Equity soared 113.97% in 2022, then sank 874.08% in 2023.
- Agenus' Common Equity stood at -$54.9 million in 2022, then plunged by 170.27% to -$148.4 million in 2023, then plunged by 106.51% to -$306.4 million in 2024, then advanced by 9.32% to -$277.9 million in 2025, then gained by 17.95% to -$228.0 million in 2026.
- Business Quant data shows AGEN's Common Equity at -$228.0 million in Q1 2026, -$277.9 million in Q4 2025, and -$280.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 20.25 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 31.71 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.61 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 5.17 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 8.57 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 9.79 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.35 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 757.49 Mn |
| 10 | Agenus | 311.95 Mn | 286.43 Mn | 34.52 Mn | -205.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -205.85 Mn |
| Mar 31, 2026 | -227.98 Mn |
| Dec 31, 2025 | -277.86 Mn |
| Sep 30, 2025 | -280.87 Mn |
| Jun 30, 2025 | -336.31 Mn |
| Mar 31, 2025 | -322.40 Mn |
| Dec 31, 2024 | -306.42 Mn |
| Sep 30, 2024 | -271.80 Mn |
| Jun 30, 2024 | -220.84 Mn |
| Mar 31, 2024 | -190.32 Mn |
| Dec 31, 2023 | -148.38 Mn |
| Sep 30, 2023 | -115.29 Mn |
| Jun 30, 2023 | -76.76 Mn |
| Mar 31, 2023 | -53.11 Mn |
| Dec 31, 2022 | -54.90 Mn |
| Sep 30, 2022 | -11.84 Mn |
| Jun 30, 2022 | 13.64 Mn |
| Mar 31, 2022 | 27.65 Mn |
| Dec 31, 2021 | 47.91 Mn |
| Sep 30, 2021 | 35.55 Mn |